1216.11.012 Boehringer Ingelheim Investigational Site
Seattle, Washington
0 studies enrolling now · 1 studies all time
What they study most
Carcinoma, Small Cell
Studies at this site
- BI 2536 Second Line Monotherapy in SCLC — Completed
Seattle, Washington
0 studies enrolling now · 1 studies all time
Carcinoma, Small Cell